Evolution News and Research

RSS

RaySearch receives order for its RayStation system from RISO

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from RISO, the Radiotherapeutic Institute in Deventer, the Netherlands.

19 Apr 2011

Exacerbate-reverse' approach can identify potential therapy for fatal childhood disease

Many genes that cause human diseases have parallel genes in other organisms, including yeast. Now Columbia University researchers have used an innovative yeast-based screening method to identify a possible treatment for the fatal childhood disease Niemann-Pick C.

19 Apr 2011

Team of researchers study development of mesoderm

During the development of an embryo, a large number of different, specialised cell-types arise from the fertilised egg. The genetic information is identical in all cells of an organism. Different properties of cells arise because the activity of genes is controlled and regulated by so called transcription factors. By switching genes on or off, the body makes muscle cells, bone cells, liver cells and many more.

16 Apr 2011

SQI enters clinical validation agreement with University North Carolina Kidney Center for Vasculitis Assay

SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based autoimmune biomarker testing, today announced it entered into a clinical validation agreement with University North Carolina Kidney Center, Chapel Hill, to evaluate SQI's new multiplexed, automated approach for biomarker detection in vasculitis.

15 Apr 2011

KCDC, KT, Gyeonggi Province and Qualcomm sign MOU for Self Quality Care project

Qualcomm Incorporated, as part of its Wireless Reach initiative, Gyeonggi Province, Korea Centers for Disease Control and Prevention, and Korea Telecom today announced the signing of a Memorandum of Understanding for a project that will benefit patients suffering from chronic disease.

12 Apr 2011

Rockefeller University professor earns recognition in developmental psychobiology

Weill Cornell Medical College and the Columbia University College of Physicians and Surgeons have announced that The Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology has been awarded to The Rockefeller University's Dr. Fernando Nottebohm for his seminal work in songbirds that has led to the discovery of neuronal replacement.

12 Apr 2011

Obesity impacts gene clock of cardiovascular system

Obese individuals typically suffer more medical problems than their leaner counterparts. They are more likely to be diagnosed with insulin resistance, diabetes, increased stress hormones, hypothyroidism, and sleep apnea. Researchers at the Georgia Health Sciences University in Augusta have also found the potential for something else, using an animal model.

12 Apr 2011

Endo Pharmaceuticals to acquire American Medical Systems

Endo Pharmaceuticals and American Medical Systems today that they have entered into a definitive agreement under which Endo will acquire AMS, a leading provider of world-class devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

11 Apr 2011

Scientists develop new approach to accelerate evolution of biomolecules in lab

Scientists at Harvard University have harnessed the prowess of fast-replicating bacterial viruses, also known as phages, to accelerate the evolution of biomolecules in the laboratory.

11 Apr 2011

Study unravels how interferon-induced factors inhibit viruses

When viruses attack, one molecule more than any other fights back. Interferon triggers the activation of more than 350 genes, and despite the obvious connection, the vast majority have never been tested for antiviral properties.

11 Apr 2011

Symposium to discuss about controversies over politicization of science

Science is playing an increasingly prominent role in many controversial political, religious and socio-economic debates, such as those about embryonic stem cells, genetically modified foods, teaching evolution and climate change.

8 Apr 2011

Visual Healthcare Lab Automation Platform gains traction with private industrial clients

Visual Healthcare Corp. announces that its new Lab Automation module is quickly gaining traction with private sector industrial clients.

8 Apr 2011

First-of-its-kind map of recombination hotspots in a multi-celled organism

Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.

6 Apr 2011

Diets may cause loss of lean muscle mass

According to boomer-generation brother and sister authors Dian Griesel, Ph.D. and Tom Griesel, every well-known diet to date is destined to deliver loss of lean muscle mass, moodiness, disappointment and failure.

5 Apr 2011

Morphotek acquires tumor targeting assets from TMI

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular, Inc. for an undisclosed upfront payment and future development milestones.

4 Apr 2011

Hospira seeks FDA 510(k) clearance for Symbiq infusion system modifications

Hospira, Inc., a leading provider of clinical information and medication delivery technologies, today announced that the company has submitted a 510(k) application with the U.S. Food and Drug Administration (FDA) for modifications to the Symbiq™ infusion system. The submission is one of the first developed to align with the recent FDA draft guidance for 510(k) infusion pump clearances.

4 Apr 2011

AtlantiCare to implement MEDai's Risk Navigator predictive analytic solution

AtlantiCare, the largest health system in southeastern New Jersey, will allow its healthcare providers to better manage patient populations and track clinical and financial objectives with quality-focused tools from Elsevier/MEDai, a leading provider of predictive analytic solutions.

4 Apr 2011

BUSPH, The Partnership at Drugfree.org collaborate to increase 'Join Together' resource utilization

The Partnership at Drugfree.org, in cooperation with the Boston University School of Public Health, announced today that Join Together has become part of the 25-year-old nonprofit organization based in New York City.

4 Apr 2011

AtlantiCare to use MEDai's Risk Navigator solutions for patient management

4 Apr 2011

New data: Quadruple therapy can effectively treat patients with HCV

Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment.

4 Apr 2011